Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines

被引:50
作者
DasGupta, SK [1 ]
Jain, S [1 ]
Kaushal, D [1 ]
Tyagi, AK [1 ]
机构
[1] Univ Delhi, Dept Biochem, New Delhi 110021, India
关键词
D O I
10.1006/bbrc.1998.8724
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful genetic engineering of mycobacteria is crucial for developing new approaches to combat tuberculosis as well as for dissecting out the molecular basis of pathogenesis of Mycobacterium tuberculosis. We have constructed a Mycobacterium-Escherichia coli shuttle expression vector pSD5. It carries a modular expression cassette which provides sites for cloning of promoters, a ribosome binding site (RBS) with an appropriately placed initiation codon and multiple cloning sites for cloning the genes of interest. We also constructed pDK20, an integration proficient derivative of pSD5, by incorporating mycobacteriophage L5 integration signals in lieu of the origin of DNA replication for mycobacteria. This vector permits stable expression of genes in M.bovis BCC, M.smegmatis, and M.tuberculosis under the transcriptional control of a mycobacterial promoter. These vectors enable the expression of a gene to be regulated by several hundred fold depending upon the strength of mycobacterial promoter. We propose that expression of protective antigens using an appropriate promoter derivative of pDK20 should help in development of recombinant BCG vaccines that can induce an optimal immune response from the host. We have further employed the integration proficient expression system for comparing the efficiency and specificity of transcriptional recognition in M.bovis BCG, M.tuberculosis, and M.smegmatis. We show that fast growing M.smegmatis and slow growing M.tuberculosis and M.bovis BCG recognize mycobacterial promoters with comparable efficiency inspite of differences in their growth rates. (C) 1998 Academic Press.
引用
收藏
页码:797 / 804
页数:8
相关论文
共 38 条
[1]   HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES TO LIVE RECOMBINANT BCG-HIV VACCINES [J].
ALDOVINI, A ;
YOUNG, RA .
NATURE, 1991, 351 (6326) :479-482
[2]   Reporter gene technology to assess activity of antimycobacterial agents in macrophages [J].
Arain, TM ;
Resconi, AE ;
Singh, DC ;
Stover, CK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1542-1544
[3]   IDENTIFICATION OF EXPRESSION SIGNALS OF THE MYCOBACTERIOPHAGE-BXB1, MYCOBACTERIOPHAGE-L1 AND MYCOBACTERIOPHAGE-TM4 USING THE ESCHERICHIA-MYCOBACTERIUM SHUTTLE PLASMID-PYUB75 AND PLASMID-PYUB76 DESIGNED TO CREATE TRANSLATIONAL FUSIONS TO THE LACZ GENE [J].
BARLETTA, RG ;
KIM, DD ;
SNAPPER, SB ;
BLOOM, BR ;
JACOBS, WR .
JOURNAL OF GENERAL MICROBIOLOGY, 1992, 138 :23-30
[4]   A study of the mycobacterial transcriptional apparatus: Identification of novel features in promoter elements [J].
Bashyam, MD ;
Kaushal, D ;
Dasgupta, SK ;
Tyagi, AK .
JOURNAL OF BACTERIOLOGY, 1996, 178 (16) :4847-4853
[5]  
Bloom Barry R., 1994, P531
[6]  
Burlein Jeanne E., 1994, P239
[7]  
CASSATT DR, 1993, VACCINES93 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P385
[8]   TUBERCULOSIS AND HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
CHAISSON, RE ;
SLUTKIN, G .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :96-100
[9]   EFFECTIVE IMMUNIZATION AGAINST CUTANEOUS LEISHMANIASIS WITH RECOMBINANT BACILLE CALMETTE-GUERIN EXPRESSING THE LEISHMANIA SURFACE PROTEINASE GP63 [J].
CONNELL, ND ;
MEDINAACOSTA, E ;
MCMASTER, WR ;
BLOOM, BR ;
RUSSELL, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11473-11477
[10]   BIOLUMINESCENCE METHOD TO EVALUATE ANTIMICROBIAL AGENTS AGAINST MYCOBACTERIUM-AVIUM [J].
COOKSEY, RC ;
MORLOCK, GP ;
BEGGS, M ;
CRAWFORD, JT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :754-756